Therapeutic Approach of Histamine H3 Receptors in Obesity

Author(s): Takayuki Masaki, Hironobu Yoshimatsu.

Journal Name: Recent Patents on CNS Drug Discovery (Discontinued)

Volume 2 , Issue 3 , 2007

Submit Manuscript
Submit Proposal

Abstract:

Obesity is considered one of the risk factors for metabolic disorders. There is increasing evidence that obesity is under control of several cytokines and hormone in the brain. Brain histamine and H3 receptors are important factors for regulating obesity. The results of physiological and pharmacological studies revealed that brain histamine and H3 receptors are involved in the regulation of obesity. In this review, we describe the implication and patent for developing H3 receptor antagonists and their therapeutic potential of obesity.

Keywords: Histamine, obesity, histamine H1 receptors, histamine H3 receptors

Rights & PermissionsPrintExport Cite as


Article Details

VOLUME: 2
ISSUE: 3
Year: 2007
Page: [238 - 240]
Pages: 3
DOI: 10.2174/157488907782411792
Price: $58

Article Metrics

PDF: 3